HSP90AA1 and colorectal cancer: Using serum CEA, CA199 and plasma HSP90α levels of healthy donors as control group, the serum CEA has significant advantages in colorectal cancer diagnosis with a cut-off value 1.77 ng/ml (AUC = 0.944, sensitivity 86.3%, specificity 87.12%, Figure 3A).